From Surf Wiki (app.surf) — the open knowledge base
Vaccination schedule
Series of vaccinations
Series of vaccinations

A vaccination schedule is a series of vaccinations, including the timing of all doses, which may be either recommended or compulsory, depending on the country of residence. A vaccine is an antigenic preparation used to produce active immunity to a disease, in order to prevent or reduce the effects of infection by any natural or "wild" pathogen. Vaccines go through multiple phases of trials to ensure safety and effectiveness. World Health Organization-guided childhood vaccine schedules protect against 30 infectious diseases, and following them is crucial to prevent risks to children and the community, having saved over 154 million lives in the past 50 years.
Many vaccines require multiple doses for maximum effectiveness, either to produce sufficient initial immune response or to boost response that fades over time. For example, tetanus vaccine boosters are often recommended every 10 years. Vaccine schedules are developed by governmental agencies or physicians groups to achieve maximum effectiveness using required and recommended vaccines for a locality while minimizing the number of health care system interactions. Over the past two decades, the recommended vaccination schedule has grown rapidly and become more complicated as many new vaccines have been developed.
Some vaccines are recommended only in certain areas (countries, sub national areas, or at-risk populations) where a disease is common. For instance, yellow fever vaccination is on the routine vaccine schedule of French Guiana, is recommended in certain regions of Brazil but in the United States is only given to travelers heading to countries with a history of the disease. In developing countries, vaccine recommendations also take into account the level of health care access, the cost of vaccines and issues with vaccine availability and storage.
Sample vaccination schedules discussed by the World Health Organization show a developed country using a schedule which extends over the first five years of a child's life and uses vaccines which cost over $700 including administration costs while a developing country uses a schedule providing vaccines in the first 9 months of life and costing only $25. This difference is due to the lower cost of health care, the lower cost of many vaccines provided to developing nations, and that more expensive vaccines, often for less common diseases, are not utilized.
Worldwide
Childhood vaccine schedules, guided by World Health Organization and developed by global experts, protect against 30 infectious diseases. Following the recommended schedule is crucial, as delays or changes increase risk for children and the community.
The World Health Organization monitors vaccination schedules across the world, noting what vaccines are included in each country's program, the coverage rates achieved and various auditing measures. The table below shows the types of vaccines given in example countries. The WHO publishes on its website current vaccination schedules for all WHO member states. Additional vaccines are given to individuals more likely to come into contact with specific diseases through work or travel (e.g. military), or after potentially infectious exposure. Examples include rabies, anthrax, cholera and smallpox.
| Country | Ref. |
|---|---|
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in | |
| Health in |
By country
Australia
The Immunise Australia Program implements the National Immunization Program (NIP) Schedule. All vaccines available under the Australian immunization schedule are free of charge under the Pharmaceutical Benefits Scheme.
| Infection | Birth | Months | Years | Preg | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Women | 2 | 4 | 6 | 12 | 18 | 4 | 12– | 14– | 15 | 50 | 65+ | 70 | Rotavirus | Hepatitis A | Hepatitis B | Diphtheria | Pertussis | Tetanus | Polio | Haemophilus influenzae | Meningococcus | Pneumococcus | Measles | Mumps | Rubella | Varicella | Human papillomavirus | Influenza | Herpes Zoster | ||||
| RV | RV | ||||||||||||||||||||||||||||||||
| HepA§ | HepA§ | ||||||||||||||||||||||||||||||||
| HepB | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | |||||||||||||||||||||||||||
| Tdap | Tdap | ||||||||||||||||||||||||||||||||
| DTaP-HepB-IPV-Hib | |||||||||||||||||||||||||||||||||
| MenACWY | MenACWY | MenACWY | MenACWY | ||||||||||||||||||||||||||||||
| PCV13 | PCV13 | PCV13 | PCV13 | PCV13 | |||||||||||||||||||||||||||||
| PCV13§ | |||||||||||||||||||||||||||||||||
| PPSV23 | PPSV23§ | PPSV23§ | PPSV23 | ||||||||||||||||||||||||||||||
| MMR | MMRV | MMRV | |||||||||||||||||||||||||||||||
| HPV x2 | HPV x2 | ||||||||||||||||||||||||||||||||
| IIV (yearly) | IIV (yearly) | ||||||||||||||||||||||||||||||||
| IIV (yearly) | |||||||||||||||||||||||||||||||||
| IIV (yearly)§ | |||||||||||||||||||||||||||||||||
| ZVL | |||||||||||||||||||||||||||||||||
| {{ubl |
Austria
Austrian vaccine recommendations are developed by the National Vaccination Board (), which is part of the Federal Ministry of Social Affairs, Health, Care and Consumer Protection.
Children aged 14 and older can be vaccinated without parental consent.
Brazil
All recommended vaccines are provide free of charge by the public health services.
| Infection | Gestation | Birth | Months | Years | 2 | 3 | 4 | 5 | 6 | 9 | 12 | 15 | 4 | 5 | 9 | 11 | 10–59 | 60+ | Tuberculosis | Leprosy | Hepatitis A | Hepatitis B | Diphtheria | Tetanus | Pertussis | Haemophilus influenzae | Polio | Pneumococcus | Meningococcus | Rotavirus | Measles | Mumps | Rubella | Varicella | Yellow fever | Human papillomavirus | Flu | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCG | ||||||||||||||||||||||||||||||||||||||||||
| HepA | ||||||||||||||||||||||||||||||||||||||||||
| HepB | 5V | 5V | 5V | |||||||||||||||||||||||||||||||||||||||
| DTPa | DTP | DTP | dT | |||||||||||||||||||||||||||||||||||||||
| IPV | IPV | IPV | OPV | OPV | ||||||||||||||||||||||||||||||||||||||
| 10v | 10v | 10v | ||||||||||||||||||||||||||||||||||||||||
| MenC | MenC | MenC | MenC | |||||||||||||||||||||||||||||||||||||||
| RV | RV | |||||||||||||||||||||||||||||||||||||||||
| MMR | MMRV | |||||||||||||||||||||||||||||||||||||||||
| VV | ||||||||||||||||||||||||||||||||||||||||||
| YF | ||||||||||||||||||||||||||||||||||||||||||
| HPVx2 (girls) | HPVx2 (boys) | |||||||||||||||||||||||||||||||||||||||||
| IIV | IIV (yearly) | IIV (yearly) |
Canada
In Canada, publicly funded immunization schedules may vary from province or territory.
Alberta
| Infection | Months | Years | 2 | 4 | 6 | 12 | 18 | 4 | 10–13 | 15–17 | 65+ | Hepatitis B | Diphtheria | Tetanus | Pertussis | Haemophilus influenzae | Pneumococcus | Polio | Measles | Mumps | Rubella | Varicella | Meningococcus | Human papillomavirus | Flu |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HepB | |||||||||||||||||||||||||
| DTaP | DTaP | DTaP | DTaP | DTaP | Tdap | ||||||||||||||||||||
| HIB | HIB | HIB | HIB | ||||||||||||||||||||||
| PneuC13 | PneuC13 | PneuC13 | |||||||||||||||||||||||
| IPV | IPV | IPV | IPV | IPV | |||||||||||||||||||||
| MMRV | MMRV | ||||||||||||||||||||||||
| MenC | MenC | MenC-ACYW | |||||||||||||||||||||||
| HPV | HPV (boys) | ||||||||||||||||||||||||
| IIV (yearly) |
British Columbia
| Infection | Months | Years | 2 | 4 | 6 | 12 | 18 | 4 | 10–13 | 15–17 | 65+ | Hepatitis B | Rotavirus | Diphtheria | Tetanus | Pertussis | Haemophilus influenzae | Pneumococcus | Polio | Measles | Mumps | Rubella | Varicella | Meningococcus | Human papillomavirus | Flu |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HepB | HepB | HepB | ||||||||||||||||||||||||
| RV | RV | |||||||||||||||||||||||||
| DTaP | DTaP | DTaP | DTaP | Tdap | ||||||||||||||||||||||
| HIB | HIB | HIB | HIB | |||||||||||||||||||||||
| PneuC13 | PneuC13 | PneuC13 | ||||||||||||||||||||||||
| IPV | IPV | IPV | IPV | IPV | ||||||||||||||||||||||
| MMR | MMRV | |||||||||||||||||||||||||
| VV | ||||||||||||||||||||||||||
| MenCCV | MenCCV | |||||||||||||||||||||||||
| HPV (girls) | ||||||||||||||||||||||||||
| IIV (yearly) |
New Brunswick
| Infection | Birth | Months | Years | 2 | 4 | 6 | 12 | 18 | 4 | 10–13 | 15–17 | 65+ | Hepatitis B | Diphtheria | Tetanus | Pertussis | Haemophilus influenzae | Pneumococcus | Polio | Measles | Mumps | Rubella | Varicella | Meningococcus | Human papillomavirus | Flu |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HepB | HepB | HepB | ||||||||||||||||||||||||
| DTaP | DTaP | DTaP | DTaP | DTaP | Tdap | |||||||||||||||||||||
| HIB | HIB | HIB | HIB | |||||||||||||||||||||||
| PneuC13 | PneuC13 | PneuC13 | ||||||||||||||||||||||||
| IPV | IPV | IPV | IPV | IPV | ||||||||||||||||||||||
| MMRV | MMRV | |||||||||||||||||||||||||
| MenCCV | MenC-ACYW | |||||||||||||||||||||||||
| HPV (girls) | ||||||||||||||||||||||||||
| IIV (yearly) |
Ontario
| Infection | Months | Years | 2 | 4 | 6 | 12 | 15 | 18 | 4 | 10–13 | 15–17 | Hepatitis B | Rotavirus | Diphtheria | Tetanus | Pertussis | Haemophilus influenzae | Pneumococcus | Polio | Measles | Mumps | Rubella | Varicella | Meningococcus | Human papillomavirus |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HepB | |||||||||||||||||||||||||
| RV | RV | ||||||||||||||||||||||||
| DTaP | DTaP | DTaP | DTaP | DTaP | Tdap | ||||||||||||||||||||
| HIB | HIB | HIB | HIB | ||||||||||||||||||||||
| PCV13 | PCV13 | PCV13 | |||||||||||||||||||||||
| IPV | IPV | IPV | IPV | IPV | |||||||||||||||||||||
| MMRV | MMRV | ||||||||||||||||||||||||
| VV | |||||||||||||||||||||||||
| MenC | MenC-ACYW | ||||||||||||||||||||||||
| HPV (girls) |
Quebec
| Infection | Months | Years | 2 | 4 | 6 | 12 | 18 | 4–6 | 9 | 14–16 | Adult | 50 | 65 | 75 | Hepatitis A | Hepatitis B | Rotavirus | Diphtheria | Tetanus | Pertussis | Haemophilus influenzae | Pneumococcus | Polio | Measles | Mumps | Rubella | Varicella | Meningococcus | Human papillomavirus | Flu |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HepA | ||||||||||||||||||||||||||||||
| HepB | HepB | HepB | HepB | |||||||||||||||||||||||||||
| RV | RV | |||||||||||||||||||||||||||||
| DTaP | DTaP | DTaP | DTaP | Tdap | Tdap | Tdap | Tdap | |||||||||||||||||||||||
| HIB | HIB | HIB | HIB | |||||||||||||||||||||||||||
| PCV10 | PCV10 | PCV10 | PPV23 | |||||||||||||||||||||||||||
| IPV | IPV | IPV | IPV | IPV | ||||||||||||||||||||||||||
| MMR | MMRV | |||||||||||||||||||||||||||||
| VV | ||||||||||||||||||||||||||||||
| MenCC | MenCC | |||||||||||||||||||||||||||||
| HPV | ||||||||||||||||||||||||||||||
| IIV | IIV | IIV | IIV (yearly) |
Finland
| Infection | Birth | Months | Years | 2 | 3 | 5 | 6 | 12 | 18 | 3 | 4 | 6 | 11–12 | 14–15 | 25 | 65+ | Tuberculosis | Rotavirus | Diphtheria | Tetanus | Pertussis | Polio | Haemophilus influenzae | Hepatitis B | Pneumococcus | Measles | Mumps | Rubella | Varicella | Human papillomavirus | Influenza | Tick-borne encephalitis |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCG | ||||||||||||||||||||||||||||||||
| RV | RV | RV | ||||||||||||||||||||||||||||||
| DTaP | DTaP | DTaP | DTaP | Tdap | Td (10yearly) | |||||||||||||||||||||||||||
| IPV | IPV | IPV | IPV | |||||||||||||||||||||||||||||
| HIB | HIB | HIB | ||||||||||||||||||||||||||||||
| HepB | ||||||||||||||||||||||||||||||||
| PCV10 | PCV10 | PCV10 | PCV13 + PPSV23 | |||||||||||||||||||||||||||||
| MMR | MMRV | |||||||||||||||||||||||||||||||
| VV | ||||||||||||||||||||||||||||||||
| HPV | ||||||||||||||||||||||||||||||||
| IIV3 | IIV3 | |||||||||||||||||||||||||||||||
| TBE |
;History :1960: Mumps vaccinations for military recruits. :1975: Measles vaccination for 1 year old children. :1975: Rubella vaccination for 11–13 years old girls and seronegative mothers. :1982: Two doses of MMR vaccination at 14–18 months and 6 years of age were introduced in the national childhood vaccination programme. :2009: Rotavirus vaccine introduced at 2, 3 and 5 months to all children (September 2009) :2010: PCV introduced at 3, 5 and 12 months of age to all children (September 2010). :2013: HPV vaccination of girls introduced :2017: Varicella vaccination introduced (1 September 2017) at 18 months, 6 years + catch-up of all born from 1 January 2006 or after with no history of varicella. :2020: HPV vaccination of boys introduced
France
| Infection | Months | Years | 0 | 1 | 2 | 4 | 6 | 11 | 12 | 13 | 15 | 16–18 | 23 | 2 | 5 | 6 | 11–13 | 25 | 45 | 65+ | Tuberculosis | Diphtheria | Tetanus | Pertussis | Polio | Haemophilus influenzae | Hepatitis B | Pneumococcus | Meningococcus | Measles | Mumps | Rubella | Human papillomavirus | Influenza | Herpes Zoster |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCG | BCG | ||||||||||||||||||||||||||||||||||
| D | D | D | D | D | d | ||||||||||||||||||||||||||||||
| TT | TT | TT | TT | TT | |||||||||||||||||||||||||||||||
| acP | acP | acP | acP | acp | |||||||||||||||||||||||||||||||
| IPV | IPV | IPV | IPV | IPV | |||||||||||||||||||||||||||||||
| Hib | Hib | Hib | |||||||||||||||||||||||||||||||||
| HepB | HepB | HepB | HepB | HepB | |||||||||||||||||||||||||||||||
| PCV | PCV | PCV | |||||||||||||||||||||||||||||||||
| MenC | |||||||||||||||||||||||||||||||||||
| MEAS | MEAS | ||||||||||||||||||||||||||||||||||
| MUMPS | MUMPS | ||||||||||||||||||||||||||||||||||
| RUMBE | RUMBE | ||||||||||||||||||||||||||||||||||
| HPV | |||||||||||||||||||||||||||||||||||
| TIV | |||||||||||||||||||||||||||||||||||
| HZ |
Germany
In Germany, a vaccination schedule is developed by the Standing Committee on Vaccination (STIKO), which operates as part of the Robert Koch Institute. The recommendations are generally adopted by the Federal Joint Committee.
| Infection | Weeks | Months | Years | 6 | 2 | 3 | 4 | 11 | 12 | 14 | 15 | 23 | 2 | 5–6 | 9 | 14 | 15 | 17 | 18–45 | 59 | 60 | Rotavirus | Diphtheria | Tetanus | Pertussis | Polio | Haemophilus influenzae | Hepatitis B | Pneumococcus | Meningococcus | Measles | Mumps | Rubella | Varicella | Human papillomavirus | Influenza | Tick-borne Encephalitis |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RV | RV | RV | |||||||||||||||||||||||||||||||||||
| D | D | D | D | D | d | d | d | d | |||||||||||||||||||||||||||||
| TT | TT | TT | TT | TT | TT | TT | TT | TT | |||||||||||||||||||||||||||||
| acP | acP | acP | acP | acP | acP | acp | acp | acp | |||||||||||||||||||||||||||||
| IPV | IPV | IPV | IPV | IPV | IPV | IPV | IPV | ||||||||||||||||||||||||||||||
| Hib | Hib | Hib | Hib | Hib | Hib | ||||||||||||||||||||||||||||||||
| HepB | HepB | HepB | HepB | HepB | HepB | ||||||||||||||||||||||||||||||||
| PCV | PCV | PCV | PCV | PCV | Pnc | PPSV23 | |||||||||||||||||||||||||||||||
| MenC | MenC | ||||||||||||||||||||||||||||||||||||
| MEAS | MEAS | MEAS | MEAS | ||||||||||||||||||||||||||||||||||
| MUMPS | MUMPS | MUMPS | |||||||||||||||||||||||||||||||||||
| RUMBE | RUMBE | RUMBE | |||||||||||||||||||||||||||||||||||
| VAR | VAR | VAR | |||||||||||||||||||||||||||||||||||
| HPV | HPV | ||||||||||||||||||||||||||||||||||||
| TIV | |||||||||||||||||||||||||||||||||||||
| TBE |
Hong Kong
Main article: Immunisation Programme in Hong Kong
In Hong Kong, Department of Health is responsible for providing free vaccinations from newborns up to primary school students.
India
In India, the standard vaccination schedule is recommended by the Indian Academy of Paediatrics(IAP). The latest schedule was the one given in 2016.
| Infection | Birth | Months | Years | 1.5 | 2.5 | 3.5 | 6 | 9 | 9-12 | 12 | 15 | 16-18 | 18 | 2 | 4–6 | 10–12 | Tuberculosis | Polio | Hepatitis B | Rotavirus | Diphtheria | Tetanus | Pertussis | Haemophilus influenzae | Pneumococcus | Polio | Measles | Mumps | Rubella | Typhoid | Hepatitis A | Varicella | Human papillomavirus |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCG | |||||||||||||||||||||||||||||||||
| OPV | OPV | OPV | OPV | ||||||||||||||||||||||||||||||
| HepB | HepB | HepB | |||||||||||||||||||||||||||||||
| RV | RV | RV | |||||||||||||||||||||||||||||||
| DTwP | DTwP | DTwP | DTwP | DTwP | Tdap | ||||||||||||||||||||||||||||
| HIB | HIB | HIB | HIB | ||||||||||||||||||||||||||||||
| PCV | PCV | PCV | PCV | ||||||||||||||||||||||||||||||
| IPV | IPV | IPV | IPV | ||||||||||||||||||||||||||||||
| MMR | MMR | MMR | |||||||||||||||||||||||||||||||
| TCV | TCV | ||||||||||||||||||||||||||||||||
| HepA | HepA | ||||||||||||||||||||||||||||||||
| VV | VV | ||||||||||||||||||||||||||||||||
| HPV (girls) |
Italy
| Infection | Birth | Months | Years | 3 | 5–6 | 11 | 13 | 15 | 5–6 | 11–18 | 65+ | Diphtheria | Tetanus | Pertussis | Polio | Haemophilus influenzae | Hepatitis B | Pneumococcus | Meningococcus | Measles | Mumps | Rubella | Varicella | Human papillomavirus | Influenza |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | D | D | D | d | |||||||||||||||||||||
| TT | TT | TT | TT | TT | |||||||||||||||||||||
| acP | acP | acP | acP | acp | |||||||||||||||||||||
| IPV | IPV | IPV | IPV | ||||||||||||||||||||||
| Hib | Hib | Hib | |||||||||||||||||||||||
| HepB | HepB | HepB | HepB | ||||||||||||||||||||||
| PCV | PCV | PCV | |||||||||||||||||||||||
| MenC | MenC | ||||||||||||||||||||||||
| MEAS | MEAS | MEAS | |||||||||||||||||||||||
| MUMPS | MUMPS | MUMPS | |||||||||||||||||||||||
| RUMBE | RUMBE | RUMBE | |||||||||||||||||||||||
| VAR | |||||||||||||||||||||||||
| HPV | |||||||||||||||||||||||||
| TIV |
Japan
The vaccination schedule in Japan is defined and partially recommended by () and its related (). As of January 2020, fourteen infections are Category A diseases and two are Category B on the legal lists. The Act and the Order were enacted for mandatory vaccination in 1948 with punitive clauses, only the clauses were repealed in 1976 and eventually vaccination has become non-mandatory since 1994.
| Infection | Act/ | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Order | |||||||||||||||||||||||||||||||||||
| (Category) | Birth | Months | Years | 2 | 3 | 6 | 12 | 24 | 36 | 60 | ≧5 | 7 | 7.5 | ||||||||||||||||||||||
| (90 mo) | 9 | 11 | 12 | 13 | 16 | 60–64 | |||||||||||||||||||||||||||||
| & 65+ | Diphtheria | Tetanus | Pertussis | Polio | Measles | Rubella | Japanese encephalitis | Tuberculosis | Haemophilus influenzae | Pneumococcus | Human papillomavirus | Smallpox | Varicella | Hepatitis B | Influenza | ||||||||||||||||||||
| Act (A) | DTaP-IPV | DT | |||||||||||||||||||||||||||||||||
| Act (A) | |||||||||||||||||||||||||||||||||||
| Act (A) | |||||||||||||||||||||||||||||||||||
| Act (A) | |||||||||||||||||||||||||||||||||||
| Act (A) | MR (1st) | MR (2nd) | |||||||||||||||||||||||||||||||||
| Act (A) | |||||||||||||||||||||||||||||||||||
| Act (A) | Japanese encephalitis (1st) | Japanese encephalitis (2nd) | |||||||||||||||||||||||||||||||||
| Act (A) | BCG | ||||||||||||||||||||||||||||||||||
| Act (A) | Hib | ||||||||||||||||||||||||||||||||||
| Act (A) | Pneumococcal | ||||||||||||||||||||||||||||||||||
| Order (B) | Pneumococcal | ||||||||||||||||||||||||||||||||||
| Act (A) | HPV vaccine | ||||||||||||||||||||||||||||||||||
| Order (A) | Not specified by the act or the order | ||||||||||||||||||||||||||||||||||
| Order (A) | Varicella | ||||||||||||||||||||||||||||||||||
| Order (A) | Hep B | ||||||||||||||||||||||||||||||||||
| Order (B) | Flu |
Only in the legal term in Japan, citizens get old one day before their birthdays. If a person was born on January 1, 2020, and Immunization Act specifies vaccine against measles could be received from age 12 months to 24 months, vaccination shall be practiced between December 31, 2020, and December 31, 2021 (not between January 2021 and January 2022.) Some vaccinations are scheduled in line with the school year system, which starts from April 1 in Japan. As explained, those who are born on April 1 and on April 2 get old legally on March 31 and April 1, respectively. Thus, these two people are in different school years and thereby they may take vaccines in different calendar years.
| Recipients | Birth | Months | Years | 2 | 3 | 6 | 12 | 24 | 36 | 60 | ≧5 | 7 | 7.5 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (90 mo) | 9 | 11 | 12 | 13 | 16 | Person A | Person B | Person C | Person D | |||||||||||||
| Dec 31, 2019 | Feb **29**, 2020 | Mar 30, 2020 | Jun 30, 2020 | Dec 30, 2020 | Dec 30, 2021 | Dec 30, 2022 | Dec 30, 2024 | Apr 1, 2025 | Mar 31, 2026 | Jun 30, 2027 | Dec 30, 2028 | Dec 30, 2030 | Apr 1, 2031 | Dec **29**, 2032 | Mar 31, 2036 | |||||||
| Jan 1, 2020 | Feb **29**, 2020 | Mar 31, 2020 | Jun **30**, 2020 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2024 | Apr 1, 2025 | Mar 31, 2026 | Jun **30**, 2027 | Dec 31, 2028 | Dec 31, 2030 | Apr 1, 2031 | Dec **30**, 2032 | Mar 31, 2036 | |||||||
| Apr 1, 2020 | May 31, 2020 | Jun 31, 2020 | Sep **30**, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2025 | Apr 1, **2025** | Mar 31, **2026** | Sep **30**, 2027 | Mar 31, 2029 | Mar 31, 2031 | Apr 1, 2031 | Mar **30**, 2033 | Mar 31, **2036** | |||||||
| Apr 2, 2020 | Jun 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Apr 1, 2021 | Apr 1, 2022 | Apr 1, 2023 | Apr 1, 2025 | Apr 1, **2026** | Mar 31, **2027** | Oct 1, 2027 | Apr 1, 2029 | Apr 1, 2031 | Apr 1, **2032** | Mar **31**, 2033 | Mar 31, **2037** |
New Zealand
| Infection | Gestation | Birth | Weeks | Months | Years | 6 | 3 | 5 | 12 | 15 | 4 | 11–12 | 13-25 | 45 | 65+ | Tuberculosis | Rotavirus | Diphtheria | Tetanus | Pertussis | Polio | Hepatitis B | Haemophilus influenzae | Pneumococcus | Meningococcus | Measles | Mumps | Rubella | Varicella | Human papillomavirus | Herpes Zoster | Influenza |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCG# | ||||||||||||||||||||||||||||||||
| RV | RV | |||||||||||||||||||||||||||||||
| Tdap | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | DTaP-IPV | Tdap | Tdap | Tdap | |||||||||||||||||||||||||
| HepB + HBIG# | ||||||||||||||||||||||||||||||||
| Hib | ||||||||||||||||||||||||||||||||
| PCV13 | PCV13# | PCV13 | PCV13 | |||||||||||||||||||||||||||||
| MenB | MenB | MenB | MenACWY + MenB# | |||||||||||||||||||||||||||||
| MMR | MMR | |||||||||||||||||||||||||||||||
| VV | VV | |||||||||||||||||||||||||||||||
| HPV9 | ||||||||||||||||||||||||||||||||
| HZ | ||||||||||||||||||||||||||||||||
| IIV | IIV# (yearly) | IIV (yearly) |
;History Major additions, replacements and removals from the New Zealand Immunization Schedule include: :1958: First Schedule: DTwP and DT :1961: Polio (OPV) added :1971: Measles, rubella and tetanus toxoid added :1979: Rubella changed to girls only :1988: HepB added :1990: MMR replaced measles and rubella :1994: HIB added; Td replaced tetanus toxoid :1996: DT dropped :1997: Influenza added :2000: DTaP replaced DTwP :2002: IPV replaced OPV :2006: MeNZB and Tdap added :2008: MeNZB dropped, PCV7 added, HPV4 added for females only :2011: PCV10 replaced PCV7 :2014: RV5 added, PCV13 replaced PCV10 :2017: HPV9 replaced HPV4 and extended to males, RV1 replaced RV5, PCV10 replaced PCV13, VV added. :2018: HZ added. :2020: Td dropped.
Nigeria
All recommended vaccines are provide free of charge by the Federal Ministry of Health.
| Infection | Birth | Months | Years | 2 | 3 | 4 | 6 | 9 | 18 | 4 | 5 | Tuberculosis | Leprosy | Hepatitis B | Diphtheria | Tetanus | Pertussis | Haemophilus influenzae | Polio | Pneumococcus | Meningococcus | Yellow fever |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BCG | ||||||||||||||||||||||
| HepB | 5V | 5V | 5V | |||||||||||||||||||
| DTP | ||||||||||||||||||||||
| OPV | OPV | OPV | OPV | OPV | OPV | |||||||||||||||||
| PCV | PCV | PCV | PCV | |||||||||||||||||||
| MCV | MCV | |||||||||||||||||||||
| YF |
Spain
| Infection | Birth | Months | Years | 2 | 4 | 6 | 12 | 18 | 3–4 | 6 | 12 | 14 | 65+ | Diphtheria | Tetanus | Pertussis | Polio | Haemophilus influenzae | Hepatitis B | Pneumococcus | Meningococcus | Measles | Mumps | Rubella | Varicella | Human papillomavirus | Influenza |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | D | D | D | d | d | d | |||||||||||||||||||||
| TT | TT | TT | TT | TT | TT | TT | |||||||||||||||||||||
| acP | acP | acP | acP | acp | |||||||||||||||||||||||
| IPV | IPV | IPV | IPV | ||||||||||||||||||||||||
| Hib | Hib | Hib | Hib | ||||||||||||||||||||||||
| HepB | HepB | HepB | |||||||||||||||||||||||||
| PCV | PCV | PCV | PPSV23 | ||||||||||||||||||||||||
| MenC | MenC | MenC | |||||||||||||||||||||||||
| MEAS | MEAS | ||||||||||||||||||||||||||
| MUMPS | MUMPS | ||||||||||||||||||||||||||
| RUMBE | RUMBE | ||||||||||||||||||||||||||
| VAR | |||||||||||||||||||||||||||
| HPV | |||||||||||||||||||||||||||
| TIV |
United Kingdom
The United Kingdom childhood vaccination schedule is recommended by the Department of Health and National Health Service, and uses combination immunisations where available.
| Infection | Months | Years | 2 | 3 | 4 | 12 | 2–10 | 3–4 | 12–13 | 13–15 | 16–18 | Diphtheria | Tetanus | Pertussis | Polio | Haemophilus influenzae | Meningococcus | Rotavirus | Pneumococcus | Hepatitis B | Measles | Mumps | Rubella | Influenza | HPV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DTaP | DTaP | DTaP | DTaP | Td | |||||||||||||||||||||
| IPV | IPV | IPV | IPV | IPV | |||||||||||||||||||||
| HIB | HIB | HIB | HIB | ||||||||||||||||||||||
| MenB | MenB | MenB/C | MenACWY | ||||||||||||||||||||||
| RV | RV | ||||||||||||||||||||||||
| PCV | PCV | ||||||||||||||||||||||||
| HepB | HepB | HepB | |||||||||||||||||||||||
| MMR | MMR | ||||||||||||||||||||||||
| LAIV | |||||||||||||||||||||||||
| HPVx2 |
Non-routine vaccinations
Some children may receive vaccines in addition to those listed in the table:
- BCG vaccine is given at birth to "children born in areas of the country where there are high numbers of TB cases" and "children whose parents or grandparents were born in a country with many cases of TB."
- Hepatitis B vaccine is given at birth to "babies born to mothers who have hepatitis B".
- The injected flu vaccine is offered annually to "children 6 months to 17 years old with long-term health conditions".
Adult vaccinations
The five scheduled childhood tetanus vaccinations are thought to generally confer lifelong immunity; thus, no routine booster doses are given in adulthood. Those adults at risk of contaminated cuts (e.g., gardeners) may have booster tetanus vaccination every ten years. Pneumococcus vaccinations (pneumococcal polysaccharide vaccine/PPV) are recommended for those over 65 and for people without a functional spleen (asplenia), either because the spleen has been removed or does not work properly. Flu vaccine is recommended for anyone who is aged 65 years and over, people with certain long-term medical conditions, health and social care professionals, pregnant women, and poultry workers. The shingles vaccine is recommended for those over 70. Additionally, pregnant women are advised to have the pertussis vaccine.
United States
The most up-to-date schedules are available from CDC's National Center for Immunization and Respiratory Diseases. In the US, the National Childhood Vaccine Injury Act requires all health-care providers to provide parents or patients with copies of Vaccine Information Statements before administering vaccines.
| Infection | Birth | Months | Years | 1 | 2 | 4 | 6 | 9 | 12 | 15 | 18 | 19–23 | 2–3 | 4–6 | 7–10 | 11–12 | 13–15 | 16 | 17–18 | 19–26 | 27–49 | 50–64 | 65+ | Hepatitis B | Rotavirus | Diphtheria | Tetanus | Pertussis | Haemophilus influenzae | Polio | Pneumococcus | Influenza | Measles | Mumps | Rubella | Varicella | Hepatitis A | Meningococcus | Human papillomavirus | Herpes Zoster |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HepB | HepB | HepB | HepB | HepB | HepB x2–3 | |||||||||||||||||||||||||||||||||||
| RV | RV | RV | ||||||||||||||||||||||||||||||||||||||
| DTaP | DTaP | DTaP | DTaP | DTaP | DTaP | DTaP | Tdap | Tdap | Tdap | Td or Tdap (every 10 years) | ||||||||||||||||||||||||||||||
| Hib | Hib | Hib | Hib | Hib | Hib | Hib | Hibx1–3 | |||||||||||||||||||||||||||||||||
| IPV | IPV | IPV | IPV | IPV | IPV | |||||||||||||||||||||||||||||||||||
| PCV13 | PCV13 | PCV13 | PCV13 | PCV13 | PCV13 | PCV13 | PCV13 | PCV13§ | ||||||||||||||||||||||||||||||||
| PPSV23 | PPSV23 x1–2 | PPSV23 | ||||||||||||||||||||||||||||||||||||||
| IIV (yearly) | IIV or LAIV (yearly) | |||||||||||||||||||||||||||||||||||||||
| MMR | MMR | MMR | MMR | MMR | MMRx1–2 | |||||||||||||||||||||||||||||||||||
| VAR | VAR | VAR | VAR | VAR x1–2 | VAR 2x | |||||||||||||||||||||||||||||||||||
| HepA | HepA x2 | HepA | HepA x2–3 | |||||||||||||||||||||||||||||||||||||
| MenACWY | MenACWY | MenACWY | MenACWY | MenACWY | MenACWY x1–2 | |||||||||||||||||||||||||||||||||||
| MenB x2–3 | ||||||||||||||||||||||||||||||||||||||||
| MenB§ | ||||||||||||||||||||||||||||||||||||||||
| HPV | HPV x2–3 | HPV | HPV | HPV§ | ||||||||||||||||||||||||||||||||||||
| RZV or ZVL | ||||||||||||||||||||||||||||||||||||||||
| {{ubl |
During pregnancy
The CDC recommends pregnant women receive some vaccines, such as the measles, mumps, rubella (MMR) vaccine a month or more before pregnancy. The Tdap vaccine (to help protect against whooping cough) is recommended during pregnancy. Other vaccines, like the flu shot, can be given before or during pregnancy, depending on whether or not it is flu season. Vaccination is safe right after giving birth, even while breastfeeding.
History
In 1900, the smallpox vaccine was the only one administered to children. By the early 1950s, children routinely received three vaccines, for protection against diphtheria, pertussis, tetanus, and smallpox, and as many as five shots by two years of age.
Vaccination has saved over 154 million lives in the past 50 years.
References
References
- "Global vaccination coverage".
- "What Is a Vaccine".
- (2006-09-21). "Tetanus: Prevention". Mayo Clinic.
- "History of Vaccine Schedule | The Children's Hospital of Philadelphia".
- Update on Yellow Fever in the Americas, http://www.paho.org/english/SHA/be_v21n2-yellowfever.htm, the Epidemiological Bulletin, Vol. 21 No. 2, June 2000, Pan American Health Organization, accessed July 18, 2007
- [http://whqlibdoc.who.int/publications/2009/9789241563864_eng.pdf State of the World's Vaccines and Immunizations (pdf)] from the [[World Health Organization]] (2003 edition)
- (22 December 2006). "WHO Vaccine Preventable Diseases Monitoring System". [[World Health Organization]].
- "Immunization schedules by antigens".
- "Immunization schedules by diseases".
- "Vaccines: VPD-VAC/List of VPDs".
- "Vaccination schedule".
- "Vaccine Scheduler {{!}} ECDC".
- "Schedule of Hong Kong Childhood Immunisation Programme".
- . (6 February 2017). ["Peraturan Menteri Kesehatan Republik Indonesia Nomor 12 Tahun 2017 Tentang Penyelanggaraan Imunisasi"](http://hukor.kemkes.go.id/uploads/produk_hukum/PMK_No._12_ttg_Penyelenggaraan_Imunisasi_.pdf). *Kemenkes*.
- "Immunise – About the Program".
- (1 April 2019). "National Immunisation Program Schedule".
- "Nationales Impfgremium". [[Federal Ministry of Social Affairs, Health, Care and Consumer Protection]].
- (1 June 2021). "Impfung: Kinder ab 14 können selbst entscheiden". [[Kurier]].
- "CALENDÁRIO NACIONAL DE VACINAÇÃO - 2019".
- "Immunization schedule tool".
- "Protocole d'immunisation du Québec (PIQ) / Calendrier régulier de vaccination".
- "Les garçons désormais vaccinés contre le VPH au Québec".
- "Vaccine Scheduler{{!}} ECDC".
- "Rokotusohjelman historia – Rokottaminen – THL".
- "Pneumokokkikonjugaattirokote eli PCV-rokote – Rokottaminen – THL".
- "THL – HPV, or human papillomavirus vaccine".
- "Vaccinating boys against HPV (human papillomavirus) has started - Press release - THL".
- (October 2014). "Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years – India, 2014 and updates on immunization". Indian Pediatrics.
- "Indian Academy of Pediatrics (IAP)".
- "予防接種とは?". 公益社団法人東京医師会 (Tokyo Medical Association, a public interest incorporated association).
- (2016-11-07). "予防接種法 (法令番号:昭和二十三年法律第六十八号); Immunization Act (Law number: Act No. 68 of 1948)". [[Ministry of Justice (Japan)]].
- (2018-03-30). "予防接種法施行令(昭和二十三年政令第百九十七号)第1条: 政令で定めるA類疾病、第1条の2: 政令で定めるB類疾病、第1条の3: 市町村長が予防接種を行う疾病及びその対象者". Administrative Management Bureau, the [[Ministry of Internal Affairs and Communications]].
- (2014). "日本のワクチン政策の変遷". [[Pharmaceutical Research and Manufacturers of America]] (PhRMA).
- (2019-11-06). "予防接種を受けるときの注意". 東京都中野区 (Nakano City Hall, Tokyo).
- (2014-03-11). "定期の予防接種における対象者の解釈について(事務連絡)". 厚生労働省健康局結核感染症課 ([[Ministry of Health, Labour and Welfare]]).
- "Q 4月1日生まれの児童生徒の学年についてどうなるのでしょうか。". 文部科学省 ([[Ministry of Education, Culture, Sports, Science and Technology]]).
- "New Zealand Immunisation Schedule". Ministry of Health (New Zealand).
- "Appendix 1: The history of immunisation in New Zealand".
- "Immunization in Nigeria".
- (2019-07-31). "NHS vaccinations and when to have them".
- "Immunisation – FAQs – Will I need more boosters in the future?".
- "Immunisation – FAQs – How often will I need this vaccine?".
- "Immunisation – Having the vaccination – Who is the vaccine for?".
- (2020-12-03). "Whooping cough vaccination in pregnancy".
- "Vaccine Information Statements: Instructions".
- "Recommended Child and Adolescent Immunization Schedule for ages 18 years or younger – United States, 2020".
- "Recommended Adult Immunization Schedule for ages 19 years or older – United States, 2020".
- (2017-07-20). "Pregnancy and Vaccination {{!}} Vaccines for Pregnant Women {{!}} CDC".
- (2017-07-24). "Get the Whooping Cough Vaccine While You Are Pregnant". Centers for Disease Control and Prevention.
- "Update on Immunization and Pregnancy Tetanus Diphtheria and Pertussis Vaccination – ACOG".
- (May 2014). "Immunization in Pregnancy and Postpartum".
- "Immunisation schedule".
- "WHO statement on autism-related issues".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Vaccination schedule — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report